{"changes":[{"companyHref":"/c/womed-fr","date":"2026-09-27","documentUrl":"https://womed.fr","domain":"womed.fr","fact":"company:added","name":"Womed","new":"added","old":"","publisher":"womed.fr","reason":null,"retrievedAt":"2026-05-08","slug":"womed-fr","status":"self-reported","url":"https://whoraisedwhat.com/c/womed-fr"},{"companyHref":"/c/womed-fr","date":"2026-09-27","documentUrl":null,"domain":"omed.fr","fact":"company:removed","name":"Womed","new":"removed","old":"present","publisher":null,"reason":"merged into womed-fr","retrievedAt":null,"slug":"womed-fr","status":null,"url":"https://whoraisedwhat.com/c/womed-fr"}],"country":"FR","description":"Womed develops intrauterine therapies built on a proprietary polymer, led by Womed Leaf, a barrier that prevents intrauterine adhesions after surgery. It targets women facing infertility, fibroids and abnormal bleeding. Its differentiator is the first physical-barrier device clinically shown to reduce adhesions.","domain":"womed.fr","employees":null,"founded":2018,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"healthtech","investors":[],"lat":50.706267,"lng":7.135959,"location":"Medical Devices","name":"Womed","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2024-04-01","investors":[],"leadInvestor":null,"leadInvestors":[],"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"womed-fr","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-08","status":"attributed","url":null},{"fact":"existence","publisher":"womed.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://womed.fr"},{"fact":"description","publisher":"womed.fr","retrievedAt":"2026-05-08","status":"self-reported","url":"https://womed.fr"}],"stage":null,"techStack":[],"totalRaisedUsd":2700000,"updatedAt":"2026-05-08"}